Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
CALL
SAP
SAP
$241B
| $34.3M | 0.01% |
139,200
+61,600
| +79% | +$14.7M |
|
1602
BorgWarner
BWA
$13.9B
| $34.3M | 0.01% |
1,077,613
+722,548
| +203% | +$24.6M |
|
1603
Associated Banc-Corp
ASB
$6.1B
| $34.2M | 0.01% |
1,431,466
+1,369,792
| +2,221% | +$33.5M |
|
1604
RxSight
RXST
$288M
| $34.2M | 0.01% |
994,167
+782,424
| +370% | +$35.3M |
|
1605
TPG
TPG
$8.45B
| $34.1M | 0.01% |
543,242
+521,380
| +2,385% | +$34.3M |
|
1606
CALL
PPG Industries
PPG
$25.4B
| $34.1M | 0.01% |
285,700
+25,700
| +10% | +$3.21M |
|
1607
PUT
Allstate
ALL
$66B
| $34.1M | 0.01% |
176,900
+1,900
| +1% | +$369K |
|
1608
PUT
NetApp
NTAP
$40.6B
| $34.1M | 0.01% |
293,600
+76,100
| +35% | +$9.3M |
|
1609
CF Industries
CF
$18B
| $34M | 0.01% |
398,711
-14,473
| -4% | -$1.25M |
|
1610
CALL
Air Products & Chemicals
APD
$68.6B
| $34M | 0.01% |
117,200
-73,500
| -39% | -$23.1M |
|
1611
CALL
Cinemark Holdings
CNK
$4.3B
| $34M | 0.01% |
1,096,900
-27,100
| -2% | -$838K |
|
1612
Ormat Technologies
ORA
$7.06B
| $33.9M | 0.01% |
499,972
+497,187
| +17,852% | +$38.4M |
|
1613
CALL
Nutanix
NTNX
$18B
| $33.8M | 0.01% |
552,900
-14,600
| -3% | -$954K |
|
|
WCN
1614
Waste Connections
WCN
$41.8B
| $33.6M | 0.01% |
195,914
+51,544
| +36% | +$9.37M |
|
1615
Brown-Forman Class B
BF.B
$13B
| $33.6M | 0.01% |
883,480
+881,715
| +49,956% | +$38.8M |
|
1616
CALL
HP
HPQ
$27.5B
| $33.5M | 0.01% |
1,027,900
-284,100
| -22% | -$10.2M |
|
1617
CG Oncology
CGON
$6.64B
| $33.5M | 0.01% |
1,169,253
+847,890
| +264% | +$29M |
|
|
1618
PUT
Boston Scientific
BSX
$75.5B
| $33.5M | 0.01% |
375,100
+88,100
| +31% | +$7.76M |
|
1619
PUT
MPLX
MPLX
$60.1B
| $33.4M | 0.01% |
698,400
+395,600
| +131% | +$18.4M |
|
1620
Palantir
PLTR
$425B
| $33.4M | 0.01% |
441,755
-66,331
| -13% | -$3.86M |
|
1621
CALL
Astera Labs
ALAB
$54.7B
| $33.4M | 0.01% |
252,000
+101,400
| +67% | +$9.52M |
|
1622
PUT
Canadian Natural Resources
CNQ
$99.4B
| $33.3M | 0.01% |
1,079,400
+237,300
| +28% | +$7.99M |
|
|
P
1623
PUT
Everpure Inc
P
$39.1B
| $33.2M | 0.01% |
540,900
+258,000
| +91% | +$14.4M |
|
1624
PUT
Kimberly-Clark
KMB
$36.8B
| $33.2M | 0.01% |
253,400
+46,600
| +23% | +$6.35M |
|
1625
First Citizens BancShares
FCNCA
$25.8B
| $33.2M | 0.01% |
15,713
+12,184
| +345% | +$25.5M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.